A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies

BACKGROUND: A major perspective for the use of circulating tumor DNA (ctDNA) in the clinical setting of non-small cell lung cancer (NSCLC) is expected as predictive factor for resistance and response to EGFR TKI therapy and, especially, as a non-invasive alternative to tissue biopsy. However, ctDNA...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:PLoS One
Prif Awduron: Jensen, Steffen Grann, Epistolio, Samantha, Madsen, Cesilie Lind, Kyneb, Majbritt Hauge, Riva, Alice, Paganotti, Alessia, Barizzi, Jessica, Petersen, Rasmus Koefoed, Børgesen, Michael, Molinari, Francesca, Boldorini, Renzo, Lorenzen, Jan, Sørensen, Erik, Christensen, Ulf Bech, Høgdall, Estrid, Frattini, Milo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2021
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8224962/
https://ncbi.nlm.nih.gov/pubmed/34166445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0253687
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg